Indraprastha Medical
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Indraprastha Medical's outlook reflects a stable revenue growth trajectory, supported by management's focus on expanding its tertiary care services amidst a competitive healthcare landscape. The company's consistent performance aligns with the broader industry trend, which is characterized by stable pricing power despite margin pressures from regulatory challenges and competitive dynamics. Management's commitment to capital allocation towards enhancing service capabilities positions Indraprastha favorably within the fragmented market, where demand for organized healthcare is on the rise. Vista's financial outlook anticipates revenue growth to remain consistent with historical performance, with profit margins expected to stabilize, reflecting the company's conservative financing structure and low leverage. The healthcare sector's positive growth trajectory, projected at a CAGR of approximately 9.44%, further supports Vista's expectations for Indraprastha. However, investors should remain vigilant regarding potential margin pressures and regulatory risks that could impact profitability. Overall, while the macroeconomic environment in India remains conducive for equity markets, the cautious investor sentiment suggests a careful approach to capital allocation in the coming 12-24 months, with opportunities in corporate healthcare being a key focus area
Why We Like This Stock
Things To Watch Out For
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 1,245 | 1,356 | 1,483 | 1,512 | 1,526 |
| Profit Before Tax (Cr.) | 167 | 217 | 246 | 252 | 254 |
| PBT Margin | 13.4% | 16.0% | 1658.8% | 16.7% | 16.6% |
| Net Profit (Cr.) | 124 | 157 | 189 | 194 | 195 |
| Earnings Per Share | 13.5 | 17.1 | 20.6 | 21.1 | 21.3 |
Analyst Recommendations
No analyst recommendations available.
Company Overview
Show Company Profile
Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India.